These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 22438557)

  • 1. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen interacts with multifunctional angiogenin to utilize its antiapoptotic functions.
    Paudel N; Sadagopan S; Chakraborty S; Sarek G; Ojala PM; Chandran B
    J Virol; 2012 Jun; 86(11):5974-91. PubMed ID: 22438557
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen and angiogenin interact with common host proteins, including annexin A2, which is essential for survival of latently infected cells.
    Paudel N; Sadagopan S; Balasubramanian S; Chandran B
    J Virol; 2012 Feb; 86(3):1589-607. PubMed ID: 22130534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kaposi's sarcoma-associated herpesvirus-induced angiogenin plays roles in latency via the phospholipase C gamma pathway: blocking angiogenin inhibits latent gene expression and induces the lytic cycle.
    Sadagopan S; Valiya Veettil M; Paudel N; Bottero V; Chandran B
    J Virol; 2011 Mar; 85(6):2666-85. PubMed ID: 21209106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kaposi's sarcoma-associated herpesvirus-positive primary effusion lymphoma tumor formation in NOD/SCID mice is inhibited by neomycin and neamine blocking angiogenin's nuclear translocation.
    Bottero V; Sadagopan S; Johnson KE; Dutta S; Veettil MV; Chandran B
    J Virol; 2013 Nov; 87(21):11806-20. PubMed ID: 23986578
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated Nrf2 Interacts with Kaposi's Sarcoma-Associated Herpesvirus Latency Protein LANA-1 and Host Protein KAP1 To Mediate Global Lytic Gene Repression.
    Gjyshi O; Roy A; Dutta S; Veettil MV; Dutta D; Chandran B
    J Virol; 2015 Aug; 89(15):7874-92. PubMed ID: 25995248
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of Kaposi's Sarcoma-Associated Herpesvirus Latency Using CRISPR-Cas9 To Edit the Latency-Associated Nuclear Antigen Gene.
    Tso FY; West JT; Wood C
    J Virol; 2019 Apr; 93(7):. PubMed ID: 30651362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus (KSHV) upregulates survivin expression in KSHV-Associated B-lymphoma cells and contributes to their proliferation.
    Lu J; Verma SC; Murakami M; Cai Q; Kumar P; Xiao B; Robertson ES
    J Virol; 2009 Jul; 83(14):7129-41. PubMed ID: 19439469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kaposi's sarcoma-associated herpesvirus upregulates angiogenin during infection of human dermal microvascular endothelial cells, which induces 45S rRNA synthesis, antiapoptosis, cell proliferation, migration, and angiogenesis.
    Sadagopan S; Sharma-Walia N; Veettil MV; Bottero V; Levine R; Vart RJ; Chandran B
    J Virol; 2009 Apr; 83(7):3342-64. PubMed ID: 19158252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Full-Length Isoforms of Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Accumulate in the Cytoplasm of Cells Undergoing the Lytic Cycle of Replication.
    Garrigues HJ; Howard K; Barcy S; Ikoma M; Moses AV; Deutsch GH; Wu D; Ueda K; Rose TM
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kaposi's sarcoma-associated herpesvirus-encoded LANA contributes to viral latent replication by activating phosphorylation of survivin.
    Lu J; Jha HC; Verma SC; Sun Z; Banerjee S; Dzeng R; Robertson ES
    J Virol; 2014 Apr; 88(8):4204-17. PubMed ID: 24478433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kaposi's sarcoma-associated herpesvirus latency in endothelial and B cells activates gamma interferon-inducible protein 16-mediated inflammasomes.
    Singh VV; Kerur N; Bottero V; Dutta S; Chakraborty S; Ansari MA; Paudel N; Chikoti L; Chandran B
    J Virol; 2013 Apr; 87(8):4417-31. PubMed ID: 23388709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kaposi's sarcoma-associated herpesvirus induces the ATM and H2AX DNA damage response early during de novo infection of primary endothelial cells, which play roles in latency establishment.
    Singh VV; Dutta D; Ansari MA; Dutta S; Chandran B
    J Virol; 2014 Mar; 88(5):2821-34. PubMed ID: 24352470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bub1 and CENP-F can contribute to Kaposi's sarcoma-associated herpesvirus genome persistence by targeting LANA to kinetochores.
    Xiao B; Verma SC; Cai Q; Kaul R; Lu J; Saha A; Robertson ES
    J Virol; 2010 Oct; 84(19):9718-32. PubMed ID: 20660191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ribosomal protein S6 interacts with the latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus.
    Chen W; Dittmer DP
    J Virol; 2011 Sep; 85(18):9495-505. PubMed ID: 21734034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recruitment of the tumour suppressor protein p73 by Kaposi's Sarcoma Herpesvirus latent nuclear antigen contributes to the survival of primary effusion lymphoma cells.
    Santag S; Jäger W; Karsten CB; Kati S; Pietrek M; Steinemann D; Sarek G; Ojala PM; Schulz TF
    Oncogene; 2013 Aug; 32(32):3676-85. PubMed ID: 22964633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Caspase Cleavage Sites in KSHV Latency-Associated Nuclear Antigen and Their Effects on Caspase-Related Host Defense Responses.
    Davis DA; Naiman NE; Wang V; Shrestha P; Haque M; Hu D; Anagho HA; Carey RF; Davidoff KS; Yarchoan R
    PLoS Pathog; 2015 Jul; 11(7):e1005064. PubMed ID: 26218605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Latency-associated nuclear antigen of Kaposi's sarcoma-associated herpesvirus recruits uracil DNA glycosylase 2 at the terminal repeats and is important for latent persistence of the virus.
    Verma SC; Bajaj BG; Cai Q; Si H; Seelhammer T; Robertson ES
    J Virol; 2006 Nov; 80(22):11178-90. PubMed ID: 16928741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bub1 in Complex with LANA Recruits PCNA To Regulate Kaposi's Sarcoma-Associated Herpesvirus Latent Replication and DNA Translesion Synthesis.
    Sun Z; Jha HC; Robertson ES
    J Virol; 2015 Oct; 89(20):10206-18. PubMed ID: 26223641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Latency-associated nuclear antigen (LANA) of Kaposi's sarcoma-associated herpesvirus interacts with origin recognition complexes at the LANA binding sequence within the terminal repeats.
    Verma SC; Choudhuri T; Kaul R; Robertson ES
    J Virol; 2006 Mar; 80(5):2243-56. PubMed ID: 16474132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Repurposing Cytarabine for Treating Primary Effusion Lymphoma by Targeting Kaposi's Sarcoma-Associated Herpesvirus Latent and Lytic Replications.
    Gruffaz M; Zhou S; Vasan K; Rushing T; Michael QL; Lu C; Jung JU; Gao SJ
    mBio; 2018 May; 9(3):. PubMed ID: 29739902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.